Post Approval Study of the remedē System

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

August 4, 2020

Study Completion Date

August 4, 2020

Conditions
Central Sleep Apnea
Trial Locations (17)

19104

University of Pennsylvania, Philadelphia

21201

University of Maryland, Baltimore, Baltimore

27103

Novant Clinical Research Institute Forsyth Medical Center, Winston-Salem

32209

UF Health Jacksonville, Jacksonville

32545

Herz-und Diabeteszentrum NRW, Bad Oeynhausen

38018

Wesley Neurology, Cordova

43210

The Ohio State University, Columbus

45219

The Lindner Center for Research & Education at The Christ Hospital, Cincinnati

54449

Marshfield Clinic, Marshfield

55102

United Heart and Vascular Clinic, Saint Paul

60515

Advocate Good Samaritan Hospital, Downers Grove

63110

Washington University in St. Louis, St Louis

64111

Saint Luke's Hospital of Kansas City, Kansas City

68526

Nebraska Heart Institute, Lincoln

78229

Methodist Hospital, San Antonio

90033

Keck Medical Center of USC, Los Angeles

08034

Cooper Health System, Cherry Hill

All Listed Sponsors
lead

Respicardia, Inc.

INDUSTRY

NCT03425188 - Post Approval Study of the remedē System | Biotech Hunter | Biotech Hunter